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Purpose: Branched-chain amino acid (BCAA) supplementation has been shown to significantly 
reduce the undesirable effects commonly associated with high-intensity training, which include 
decreases in muscle function and increases in muscle soreness. However, the application of 
associated BCAA research to the athletic setting is limited, as supplementation protocols have 
contained either low (3 - 6g), or high (20g) dosages of BCAA, generally administered to untrained 
individuals. The present study investigated the acute effects of two different quantities of BCAA on 
the recovery of muscle function following high-intensity resistance training in trained individuals. 
The main aim was to examine whether there is a dose-response effect of using a higher dosage of 
BCAA on recovery when compared to a lower dosage.  
 
Methods: Five resistance-trained males (mean ± SD, age: 21.8 ± 0.8 years, stature: 1.81 ± 0.57 m, 
body mass: 83.3 ± 7.2 kg) were recruited and performed baseline assessments including, 
countermovement (CMJ) and squat jump (SJ), peak (PP) and mean (MP) power (6 s Wingate Cycle) 
and perceived muscle soreness (soreness). In a counterbalanced, single-blind fashion, participants 
were provided with either, placebo (blackcurrant squash with negligible calorie content) or 6g or 18g 
BCAA 20 min prior to, and immediately after completion of a high-intensity strength session (ST). At 
24 h post ST, all assessments were completed under all three experimental conditions. 
 
Results: Following ST, there were significant decrements in all measures of muscle function across 
conditions when compared to baseline values (p < 0.05). However, ingestion of 6g and 18g BCAA was 
shown to significantly attenuate these decrements in comparison to placebo (p < 0.05). A dose-
response for BCAA was also present as significant differences (p < 0.05) were shown between 
ingestion of 6g and 18g; CMJ (18g: 59.1 cm, 6g: 57.7 cm, placebo: 56.6cm), SJ (18g: 54.0 cm, 6g: 52.8 
cm, placebo: 51.7 cm), PP (18g: 1133 W, 6g: 1107 W, placebo: 1044 W), MP (18g: 1011 W, 6g: 986 
W, placebo: 972 W), soreness (18g: 81 mm, 6g: 91 mm, placebo: 100 mm).  
 
Conclusions: BCAA ingested both acutely before, and immediately following intensive resistance 
training attenuates the decrement observed in muscle function, while alleviating symptoms of 
muscle soreness. These small but significant findings not only support the proposed ergogenic 
benefits of BCAA supplementation, but also highlight a potential dose-response, with a higher dose 
(18g) having a significantly greater effect than a lower dose (6g) in trained individuals. 
